Center For Scientific Review; Notice of Closed Meetings, 54778-54779 [2011-22542]

Download as PDF 54778 Federal Register / Vol. 76, No. 171 / Friday, September 2, 2011 / Notices Information about becoming a member on an FDA advisory committee can also be obtained by visiting FDA’s Web site by using the following link: https://www.fda.gov/ AdvisoryCommittees/default.htm. SUPPLEMENTARY INFORMATION: FDA is requesting nomination for voting members on the Tobacco Products Scientific Advisory Committee. I. General Description of the Committee Duties The Tobacco Products Scientific Advisory Committee (the Committee) advises the Commissioner of Food and Drugs (the Commissioner) or designee in discharging responsibilities as they relate to the regulation of tobacco products. The Committee reviews and evaluates safety, dependence, and health issues relating to tobacco products and provides appropriate advice, information and recommendations to the Commissioner. II. Criteria for Voting Members Members and the Chair are selected by the Commissioner or designee from among individuals knowledgeable in the fields of medicine, medical ethics, science, or technology involving the manufacture, evaluation, or use of tobacco products. Members will be invited to serve for terms of up to 4 years. The Committee shall include nine technically qualified voting members, selected by the Commissioner or designee. The nine voting members shall be physicians, dentists, scientists, or health care professionals practicing in the area of oncology, pulmonology, cardiology, toxicology, pharmacology, addiction, or any other relevant specialty. erowe on DSK5CLS3C1PROD with NOTICES III. Nomination Procedures Any interested person may nominate one or more qualified individuals for membership on the advisory committee. Self-nominations are also accepted. Nominations must include a current, complete resume or curriculum vitae for each nominee, including current business address and/or home address, telephone number, and e-mail address if available. Nominations must also specify the advisory committee for which the nominee recommended. Nomination must also acknowledge that the nominee is aware of the nomination unless self-nominated. FDA will ask potential candidates to provide detailed information concerning such matters related to financial holdings, employment, and research grants and/or contracts to permit evaluation of possible sources of conflicts of interest. VerDate Mar<15>2010 15:37 Sep 01, 2011 Jkt 223001 This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees. Dated: August 30, 2011. Jill Hartzler Warner, Acting Associate Commissioner for Special Medical Programs. [FR Doc. 2011–22548 Filed 9–1–11; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Library of Medicine; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Literature Selection Technical Review Committee. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended because the premature disclosure of journals as potential titles to be indexed by the National Library of Medicine and the discussions would likely to significantly frustrate implementation of recommendations. Name of Committee: Literature Selection Technical Review Committee. Date: October 27–28, 2011. Open: October 27, 2011, 9 a.m. to 11 a.m. Agenda: Administrative. Place: National Library of Medicine, Building 38, 2nd Floor, Board Room, 8600 Rockville Pike, Bethesda, MD 20894. Closed: October 27, 2011, 11 a.m. to 5 p.m. Agenda: To review and evaluate journals as potential titles to be indexed by the National Library of Medicine. Place: National Library of Medicine, Building 38, 2nd Floor, Board Room, 8600 Rockville Pike, Bethesda, MD 20894. Closed: October 28, 2011, 8:30 a.m. to 2 p.m. Agenda: To review and evaluate journals as potential titles to be indexed by the National Library of Medicine. Place: National Library of Medicine, Building 38, 2nd Floor, Board Room, 8600 Rockville Pike, Bethesda, MD 20894. Contact Person: Sheldon Kotzin, MLS, Associate Director, Division of Library Operations, National Library of Medicine, PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 8600 Rockville Pike, Building 38, Room 2W06, Bethesda, MD 20892, 301–496–6921, kotzins@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. (Catalogue of Federal Domestic Assistance Program No. 93.879, Medical Library Assistance, National Institutes of Health, HHS). Dated: August 29, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–22601 Filed 9–1–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center For Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Musculoskeletal, Oral and Skin Sciences Integrated Review Group, Musculoskeletal Tissue Engineering Study Section. Date: September 29–30, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Jean D. Sipe, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4106, E:\FR\FM\02SEN1.SGM 02SEN1 erowe on DSK5CLS3C1PROD with NOTICES Federal Register / Vol. 76, No. 171 / Friday, September 2, 2011 / Notices MSC 7814, Bethesda, MD 20892. 301–435– 1743. smithbf@auburn.edu. Name of Committee: Emerging Technologies and Training Neurosciences Integrated Review Group, Molecular Neurogenetics Study Section. Date: September 29, 2011. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Eugene Carstea, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD 20892. (301) 408– 9756. carsteae@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, PAR10–174: International Research Ethics Education and Curriculum Development. Date: October 4, 2011. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hotel Monaco Alexandria, 480 King Street, Alexandria, VA 22314. Contact Person: Karin F. Helmers, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3166, MSC 7770, Bethesda, MD 20892. 301–254– 9975. helmersk@csr.nih.gov. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group, Clinical Neuroscience and Neurodegeneration Study Section. Date: October 5–6, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: One Washington Circle Hotel, One Washington Circle, NW., Washington, DC 20037. Contact Person: Samuel C. Edwards, PhD, Chief, Brain Disorders and Clinical Neuroscience, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5210, MSC 7846, Bethesda, MD 20892. (301) 435–1246. edwardss@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Neurotechnology Overflow. Date: October 5–6, 2011. Time: 8 a.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: Melrose Hotel, 2430 Pennsylvania Avenue, NW., Washington, DC 20037. Contact Person: Yvonne Bennett, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5199, MSC 7846, Bethesda, MD 20892. 301–379– 3793. bennetty@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: Skeletal Muscle and Dermatology. Date: October 5, 2011. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. VerDate Mar<15>2010 15:37 Sep 01, 2011 Jkt 223001 Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call). Contact Person: Aruna K. Behera, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4211, MSC 7814, Bethesda, MD 20892. 301–435– 6809. beheraak@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: August 29, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–22542 Filed 9–1–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [Docket ID FEMA–2011–0014; OMB No. 1660–0020] Agency Information Collection Activities: Submission for OMB Review; Comment Request, Write Your Own (WYO) Program Federal Emergency Management Agency, DHS. ACTION: Notice. AGENCY: The Federal Emergency Management Agency (FEMA) has submitted the following information collection to the Office of Management and Budget (OMB) for review and clearance in accordance with the requirements of the Paperwork Reduction Act of 1995. The submission describes the nature of the information collection, the categories of respondents, the estimated burden (i.e., the time, effort and resources used by respondents to respond) and cost, and includes the actual data collection instruments FEMA will use. SUPPLEMENTARY INFORMATION: Title: Write Your Own (WYO) Program. OMB Number: 1660–0020. Abstract: FEMA enters into arrangements with individual private sector insurance companies that are licensed to engage in the business of property insurance. These companies may offer flood insurance coverage to eligible property owners utilizing their customary business practices. WYO Companies are expected to meet the recording and reporting requirements of SUMMARY: PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 54779 the WYO Transaction Record Reporting and Processing Plan. Affected Public: Business or other forprofit. Number of Respondents: 88. Estimated Time per Respondent: 0.59 hours. Estimated Total Annual Burden Hours: 623 hours. Frequency of Response: Monthly. Comments: Interested persons are invited to submit written comments on the proposed information collection to the Office of Information and Regulatory Affairs, Office of Management and Budget. Comments should be addressed to Desk Officer for the Department of Homeland Security, Federal Emergency Management Agency, and sent via electronic mail to oira.submission@omb.eop.gov or faxed to (202) 395–6974. Comments must be submitted on or before October 3, 2011. FOR FURTHER INFORMATION CONTACT: Requests for additional information or copies of the information collection should be made to Director, Records Management Division, 500 C Street, SW., Washington, DC 20472, Mail Drop Room 301, 1800 S. Bell Street, Arlington, VA 22202, facsimile number (202) 646–3347, or e-mail address FEMA-Information-Collections@dhs.gov. Lesia M. Banks, Director, Records Management Division, Office of the Chief Administrative Officer, Federal Emergency Management Agency, Department of Homeland Security. [FR Doc. 2011–22464 Filed 9–1–11; 8:45 am] BILLING CODE 9111–52–P DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [Internal Agency Docket No. FEMA–4014– DR; Docket ID FEMA–2011–0001] Nebraska; Amendment No. 1 to Notice of a Major Disaster Declaration Federal Emergency Management Agency, DHS. ACTION: Notice. AGENCY: This notice amends the notice of a major disaster declaration for the State of Nebraska (FEMA–4014–DR), dated August 12, 2011, and related determinations. SUMMARY: DATES: Effective Date: August 25, 2011. FOR FURTHER INFORMATION CONTACT: Peggy Miller, Office of Response and Recovery, Federal Emergency Management Agency, 500 C Street, SW., Washington, DC 20472, (202) 646–3886. E:\FR\FM\02SEN1.SGM 02SEN1

Agencies

[Federal Register Volume 76, Number 171 (Friday, September 2, 2011)]
[Notices]
[Pages 54778-54779]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-22542]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center For Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Musculoskeletal, Oral and Skin Sciences 
Integrated Review Group, Musculoskeletal Tissue Engineering Study 
Section.
    Date: September 29-30, 2011.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Jean D. Sipe, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4106,

[[Page 54779]]

MSC 7814, Bethesda, MD 20892. 301-435-1743. smithbf@auburn.edu.

    Name of Committee: Emerging Technologies and Training 
Neurosciences Integrated Review Group, Molecular Neurogenetics Study 
Section.
    Date: September 29, 2011.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road, NW., Washington, DC 20015.
    Contact Person: Eugene Carstea, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD 20892. (301) 408-
9756. carsteae@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, PAR10-174: International Research Ethics Education and 
Curriculum Development.
    Date: October 4, 2011.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hotel Monaco Alexandria, 480 King Street, Alexandria, VA 
22314.
    Contact Person: Karin F. Helmers, PhD, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3166, MSC 7770, Bethesda, MD 
20892. 301-254-9975. helmersk@csr.nih.gov.

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group, Clinical Neuroscience and Neurodegeneration 
Study Section.
    Date: October 5-6, 2011.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: One Washington Circle Hotel, One Washington Circle, NW., 
Washington, DC 20037.
    Contact Person: Samuel C. Edwards, PhD, Chief, Brain Disorders 
and Clinical Neuroscience, Center for Scientific Review, National 
Institutes of Health, 6701 Rockledge Drive, Room 5210, MSC 7846, 
Bethesda, MD 20892. (301) 435-1246. edwardss@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Neurotechnology Overflow.
    Date: October 5-6, 2011.
    Time: 8 a.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Melrose Hotel, 2430 Pennsylvania Avenue, NW., Washington, 
DC 20037.
    Contact Person: Yvonne Bennett, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5199, MSC 7846, Bethesda, MD 20892. 301-379-
3793. bennetty@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Member Conflict: Skeletal Muscle and Dermatology.
    Date: October 5, 2011.
    Time: 1 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892. (Telephone Conference Call).
    Contact Person: Aruna K. Behera, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4211, MSC 7814, Bethesda, MD 20892. 301-435-
6809. beheraak@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: August 29, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-22542 Filed 9-1-11; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.